Lichen Sclerosus

Perianal Lichen Sclerosus (LS)

Lichen Sclerosus (LS) is a chronic inflammatory skin disease that primarily affects the anogenital areas. The disease causes a progressive change in the skin's connective tissue, leading to inflammation, scarring, and loss of elasticity. Although LS is best known for affecting the external genitalia (vulva/penis), it is important to recognise that it can also involve the skin around the anus (perianal Lichen Sclerosus).

LS is a benign but chronic condition. Without correct and persistent treatment, there is a risk of permanent anatomical changes and, in rare cases, the development of cellular changes (dysplasia).

---

What causes Lichen Sclerosus?

The precise underlying cause of Lichen Sclerosus is still the subject of research, but the strongest theory points towards an autoimmune origin combined with other predisposing factors.

• Autoimmune dysfunction (Main cause): The body's immune system produces antibodies that mistakenly attack the delicate skin cells (fibroblasts and keratinocytes) in the affected areas. This leads to a chronic inflammatory cascade, resulting in the characteristic thickening, scarring, and atrophy (thinning) of the skin.
• Hormonal connection: The disease is seen more frequently during periods of low oestrogen levels (before puberty and after menopause in women), indicating a possible hormonal sensitivity in the tissue, although this is not the sole cause.
• Genetic predisposition: Clinical observations suggest there may be a hereditary component, as the disease is sometimes seen in several members of the same family or in association with other autoimmune disorders.
• Important: Not contagious: LS is not an infection and can under no circumstances be transmitted sexually or through ordinary contact.

---

Symptoms of Perianal Lichen Sclerosus

The symptom profile develops gradually. In the perianal area, symptoms often have a significant impact on the patient's quality of life.

Symptom	Description and Consequence
Itching (Pruritus)	The most bothersome symptom. The itching is often intense, burning, and typically worsens at night, which can disrupt sleep and daily functioning. Constant scratching can exacerbate inflammation and cause further tearing.
Pain and Discomfort	Pain may occur during bowel movements (defaecation) or at rest. This is often due to tightness in the skin, anal fissures (painful tears), or secondary infection.
Characteristic Skin Changes	The skin takes on a whitish, pale, parchment-like appearance and feels thin and wrinkled (atrophic). In active phases, redness and swelling (erythema) may be seen.
Scarring and Tightness	Chronic inflammation leads to the formation of hard, fibrous scar tissue. In the perianal area, this can result in a loss of elasticity and a narrowing (stricture) of the anal opening, which can cause difficulties with bowel movements.
Fissures and Sores	Atrophic and tight skin is very fragile. Even slight stretching or wiping can cause painful cracks and sores that are difficult to heal.

---

Diagnosis and Investigation (The Procedure)

An accurate diagnosis is crucial to starting the correct treatment and ruling out other skin diseases.

• Clinical Examination: The diagnosis is initially made by a doctor or surgeon experienced in anogenital skin diseases. The examination focuses on identifying the typical white, atrophic changes and scarring around the anus.

• Tissue Sample (Biopsy) - The Gold Standard: To confirm the diagnosis and rule out premalignant (cellular changes) or malignant changes, a biopsy is often necessary.

  • Procedure: A small piece of tissue is removed under local anaesthetic and sent for microscopic analysis. This is a quick and minimally invasive procedure.
  • Purpose: The biopsy confirms the histopathological signs of LS and provides reassurance that it is not another, more serious condition.

---

Treatment of Perianal Lichen Sclerosus (The Strategy)

The goal of treatment is to extinguish the inflammation, restore skin flexibility, and minimise the risk of long-term complications. Treatment is lifelong and requires patient commitment.

1. Topical Steroid Treatment (The Primary Treatment)

• Medication: Potent steroid preparations (usually Clobetasol propionate in ointment or cream form) are the most effective and primary treatment.
• Mechanism of Action: Steroids significantly suppress the autoimmune reaction in the skin, thereby reducing inflammation, itching, and scarring.
• Treatment Plan (Example):
  • Initial Intensive Phase: Typically 1-2 times daily for a period of 4-12 weeks, until symptoms are under full control.
  • Maintenance Phase: Once the skin is stable, the dose is tapered down to 1-2 times weekly. This maintenance is critical to prevent relapse and scarring.

2. Supplementary and Supportive Treatment

• Emollients (Barrier Creams): The application of fatty creams or pure petroleum jelly (Vaseline) is essential. These products keep the skin supple and hydrated and act as a barrier, reducing irritation from stool and friction.
• Calcineurin Inhibitors: Creams such as Tacrolimus or Pimecrolimus can be used as an alternative to steroids, especially for maintenance or if steroids are not tolerated/do not have sufficient effect.
• Hygiene and Care:
  • Avoid Irritants: Use only lukewarm water and mild bath oil in the area. Perfumed soaps, wet wipes, or harsh cleaning agents must be avoided.
  • Gentle Drying: Avoid rubbing the skin dry. Pat gently or use a hair dryer on a low heat setting.

3. Surgical Intervention (In Case of Complications)

Surgery is a rare exception and is only used if the disease has caused serious complications that cannot be resolved medically.

• Treatment of Stricture: If scarring has led to a significant narrowing of the anal opening (anal stenosis), a surgical widening (anoplasty/sphincterotomy) may be necessary to restore normal bowel function.
• Removal of Cellular Changes: If repeated biopsies show persistent severe cellular changes (premalignant lesions), surgical removal of the affected tissue is necessary to prevent the development of squamous cell carcinoma.

---

Long-term Outlook and Self-care

• Lifelong Monitoring: LS is a chronic condition and requires lifelong attention and maintenance treatment. The goal is to keep the disease in remission and thereby achieve complete symptom relief.
• Regular Oncological Monitoring: The increased-albeit small-risk of developing squamous cell carcinoma (skin cancer) in chronic LS-affected tissue means that regular check-ups (typically annually) with your surgeon or dermatologist are mandatory - even when you are symptom-free.
• Persistence Pays Off: Follow the doctor's instructions closely. It can take months to see the full effect of steroid treatment, but persistence is key to preventing permanent damage.

Reference List: Perianal Lichen Sclerosus

1. Pathophysiology and Epidemiology

1. General Understanding of Lichen Sclerosus (Autoimmune and Chronic Nature):

   • Source: Kirtschig, G. (2016). Lichen Sclerosus-Looking Back and Moving Forward. Acta Dermato-Venereologica, 96(2), 149-156.

   • Link: https://pubmed.ncbi.nlm.nih.gov/26658925/

   • Supports: Description of LS as a chronic inflammatory skin disease, the autoimmune hypothesis, and how it leads to loss of elasticity and scarring (atrophy/fibrosis).

2. Lichen Sclerosus' Connection to other Autoimmune Diseases and Hormones:

   • Source: Kreuter, A. (2018). Lichen sclerosus. The Lancet, 391(10118), 350-358.

   • Link: https://pubmed.ncbi.nlm.nih.gov/28993188/

   • Supports: The theory of an autoimmune origin, possible genetic predisposition, and the observed hormonal connection (e.g., menopause).

2. Diagnostics and Symptoms

3. Clinical Presentation, Role of Biopsy, and Presentation in the Perianal Area:

   • Source: Meffert, J. J., & Crotty, K. (2020). Extragenital and anogenital lichen sclerosus: An update. Journal of the American Academy of Dermatology, 83(2), 335-343.

   • Link: https://pubmed.ncbi.nlm.nih.gov/31336087/

   • Supports: Symptoms (intense itching, pain, fissures) and characteristic skin changes (white, parchment-like appearance, scarring). The source also confirms the importance of a biopsy to confirm the diagnosis and rule out malignancy.

3. Treatment and Complications

4. Topical Steroid Treatment as First Choice (Clobetasol Propionate):

   • Source: Kirtschig, G., Becker, K., Günthert, A., Jasaitiene, D., Neumann, C., Röcken, M., Rueff, F., & Stockfleth, E. (2015). S1-Guideline: Lichen sclerosus. Journal der Deutschen Dermatologischen Gesellschaft, 13(10), 1076-1092.

   • Link: https://pubmed.ncbi.nlm.nih.gov/26458564/

   • Supports: The treatment strategy establishing potent topical steroids (e.g., Clobetasol propionate) as the primary and most effective treatment in both intensive and maintenance phases.

5. Risk of Cancer Development (Squamous Cell Carcinoma - SCC) and Monitoring:

   • Source: Yesudian, P. D., & Sugunendran, H. (2019). Anogenital lichen sclerosus and its malignant potential. Current Dermatology Reports, 8(3), 195-203.

   • Link: https://pubmed.ncbi.nlm.nih.gov/32047879/

   • Supports: The claim of an increased risk of developing squamous cell carcinoma in chronic LS tissue, necessitating regular oncological monitoring.

6. Surgical Intervention for Complications (Stricture/Anal Stenosis):

   • Source: Al-Daraji, W., & Singh, N. (2015). Perianal lichen sclerosus: a brief overview and update. Pathology, 47(7), 676-680.

   • Link: https://pubmed.ncbi.nlm.nih.gov/26620953/

   • Supports: The necessity of surgical intervention in rare cases where scarring has led to a functionally limiting stricture (narrowing) requiring widening.